COVID-19 Updates

Johnson and Johnson Vaccine - Effective April 23, 2021, CDC and FDA recommend that use of the Janssen COVID-19 Vaccine resume in the United States. However, women younger than 50 years old should be made aware of a rare risk of blood clots with low platelets following vaccination and the availability of other COVID-19 vaccines where this risk has not been observed. Read the CDC/FDA statement. On April 13th, the FDA and CDC, out of an abundance of caution, recommended pausing administration of the Johnson and Johnson (J&J) COVID-19 vaccine. Click here to read the MedStar Health Provider Alert for more details and recommendations.

For the most up-to-date information regarding the J&J vaccine, please visit:

The following is a listing of recent updates and changes made by MedStar Family Choice in response to the Novel Coronavirus (COVID-19).

COVID-19 updates for MedStar Family Choice providers:

NOTE: Maryland Poison Center has issued their ToxTibits newletter regarding the dangers of chloroquine and hydroxychloroquine medications for treatment of COVID-19.

For additional information and resources from the Maryland Department of Health, please visit the COVID-19 Provider Updates Webpage. The Resources for Health Care Professionals Webpage on Maryland.gov also has a Medicaid heading with the appeals extension, authorization update, teleheath and telephonic services guidance.

Information current as of: 04/26/21